GLRX2 and carcinoma: It is important to note that the GRX2 gene and other oxidoreductases from the Trx family are often found to be upregulated in various types of carcinomas, leading to increased resistance to chemotherapy, increased proliferation of cancer cells and decreased survival rates of patients [31].